NKA Bio | Techstars '24

When minutes count, our drug buys hours!

General Information
Company Name
NKA Bio | Techstars '24
Founded Year
2023
Location (Offices)
Baltimore, United States +1
Founders / Decision Makers
Number of Employees
3
Industries
Biotechnology, Life Sciences, Medical Devices
Funding Stage
Seed
Social Media

NKA Bio | Techstars '24 - Company Profile

NKA Bio is developing new medicines to improve critical care. Our lead product is NKA01, a temperature-stable antibody for trauma patients. When you are severely injured, it is a race against time to get to surgery. The average person dies 8 minutes before lifesaving treatment can be delivered. But in the future, when minutes count, our antibody will buy hours. At NKA Bio, our treatment presses pause on death. With an injection of NKA01 by EMS, our drug could buy more time for transport and lifesaving surgery.

Funding Rounds & Investors of NKA Bio | Techstars '24 (0)

View All

There is no investment information

Latest News of NKA Bio | Techstars '24

View All

No recent news or press coverage available for NKA Bio | Techstars '24.

Similar Companies to NKA Bio | Techstars '24

View All
Planet Biotechnology, Inc. - Similar company to NKA Bio | Techstars '24
Planet Biotechnology, Inc. Developing promising antibodies and receptor/ligand-Fc fusion proteins for the treatment and prevention of disease
Novus Diagnostics - Similar company to NKA Bio | Techstars '24
Novus Diagnostics Developing ground-breaking diagnostics technologies that provide rapid answers right at the patient’s bedside
Aster Bio - Similar company to NKA Bio | Techstars '24
Aster Bio Using molecular testing (qPCR & MCA) for optimizing wastewater treatment & development of bioaugmentation cultures.
Blue Sky Bio, LLC - Similar company to NKA Bio | Techstars '24
Blue Sky Bio, LLC Your Partner in Digital Dentistry
Developeration AB - Similar company to NKA Bio | Techstars '24
Developeration AB Developing surgery for life